StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 9/30
$1.99−0.02 (-1.00%)

Close on Nov 12, 2026Market cap $73.19MP/E –Yield –

Fortress Biotech enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Fortress Biotech's enterprise value was -$53.07M on Nov 11, 2026, against $58.31M a year earlier. Over the last 5 years it ranged from -$85.87M to $156.43M, with a median of -$3.27M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$53.07M-162.9%
2025Dec 31, 2025$84.36M+441.4%
2024Dec 31, 2024$15.58M–
2023Dec 29, 2023-$29.53M–
2022Dec 30, 2022-$7.14M-104.6%
2021Dec 31, 2021$156.43M-25.2%
2020Dec 31, 2020$209.21M+46.8%
2019Dec 31, 2019$142.48M+214.7%
2018Dec 31, 2018$45.28M-70.7%
2017Dec 29, 2017$154.33M+37.8%
2016Dec 30, 2016$112.01M+23.6%
2015Dec 31, 2015$90.59M+79.4%
2014Dec 31, 2014$50.49M–
2013Dec 31, 2013-$5.14M-100.0%
2012Dec 31, 2012$109.89B+579037.1%
2011Dec 30, 2011$18.97M–

More Fortress Biotech figures

See a number that looks wrong?